Indication
Child-Pugh Class B
1 clinical trial
2 products
Clinical trial
International Randomized Study of Transarterial Chemoembolization (TACE) Versus Stereotactic Body Radiotherapy (SBRT) / Stereotactic Ablative Radiotherapy (SABR) for Residual or Recurrent Hepatocellular Carcinoma After Initial TACEStatus: Terminated, Estimated PCD: 2022-12-31
Product
Embolic agentProduct
lipiodol